Lactobacillus rhamnosus GG (LGG) effectively modulates the gut microecological balance and enhances intestinal barrier function through its exceptional ability to colonize the gut. By supporting digestive system health, it simultaneously helps activate and strengthen the immune response. These dual health benefits have been substantiated by extensive clinical research, establishing LGG as a gold-standard strain in the field of pediatric digestive and immune health.
This robust efficacy is rooted in its rigorous scientific selection process and exceptionally high viable cell concentration. LGG was meticulously selected from over 30,000 strains specifically to deliver targeted health benefits. Furthermore, its ultra-high concentration of up to 300 billion CFU/g ensures efficient colonization even at low dosages, providing strong support for children's gastrointestinal and immune systems.
In terms of quality assurance and clinical validation, LGG sets an industry benchmark. The product utilizes advanced VPro-5 layer microencapsulation technology and is packaged with cold chain logistics (including ice packs). It can be stored in refrigerated conditions for up to two weeks or frozen for long-term preservation, ensuring optimal stability and efficacy during transportation and storage. Additionally, rigorous comparative clinical studies have demonstrated that LGG significantly outperforms placebo in supporting the management of acute gastroenteritis in children, providing brand owners with compelling scientific backing for developing premium pediatric health products.